The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge

Antiviral Research

Volumn 93, Issue 3, 2012, Pages 416-428

  Martinez, Osvaldo ^a   Leung, Lawrence W ^a   Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presenting cell; Dendritic cell; Ebola virus; Filovirus; Interferon; Macrophage; Marburg virus

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIVIRUS AGENT; B7 ANTIGEN; BETA INTEGRIN; CD123 ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CYTOKINE; FOLATE RECEPTOR 1; FURIN; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; KIDNEY INJURY MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; N ACETYLGALACTOSAMINE; NIEMANN PICK DISEASE TYPE C 1 PROTEIN; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; THROMBOPLASTIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; BLOOD CLOTTING; CELL MATURATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG RESPONSE; EBOLA VIRUS; FILOVIRAL HEMORRHAGIC FEVER; FILOVIRUS; FILOVIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MACROPHAGE; MARBURG VIRUS; MONOCYTE; MONONUCLEAR PHAGOCYTE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS HEMORRHAGIC FEVER; VIRUS LIKE AGENT; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; EBOLAVIRUS; FILOVIRIDAE INFECTIONS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; MARBURGVIRUS;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS;

EID: 84857483349     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.01.011     Document Type: Review

References (178)

1. Aleksandrowicz P., Marzi A., Biedenkopf N., Beimforde N., Becker S., Hoenen T., Feldmann H., Schnittler H.J. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. Journal of Infectious Diseases 2011, 204(Suppl 3):S957-967.
2. Aleksandrowicz P., Wolf K., Falzarano D., Feldmann H., Seebach J., Schnittler H. Viral haemorrhagic fever and vascular alterations. Hamostaseologie 2008, 28:77-84.
3. Allavena P., Chieppa M., Monti P., Piemonti L. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Critical Reviews in Immunology 2004, 24:179-192.
4. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. Journal of Virology 2002, 76:6841-6844.
5. Bale S., Liu T., Li S., Wang Y., Abelson D., Fusco M., Woods V.L., Ollmann Saphire E. Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion. PLoS Negl Trop Dis 2011, 5:e1395.
6. Bar S., Takada A., Kawaoka Y., Alizon M. Detection of cell-cell fusion mediated by Ebola virus glycoproteins. Journal of Virology 2006, 80:2815-2822.
7. Basler C.F., Amarasinghe G.K. Evasion of interferon responses by Ebola and Marburg viruses. Journal of Interferon and Cytokine Research 2009, 29:511-520.
8. Basler C.F., Mikulasova A., Martinez-Sobrido L., Paragas J., Muhlberger E., Bray M., Klenk H.D., Palese P., Garcia-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. Journal of Virology 2003, 77:7945-7956.
9. Basler C.F., Wang X., Muhlberger E., Volchkov V., Paragas J., Klenk H.D., Garcia-Sastre A., Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 2000, 97:12289-12294.
10. Baum A., Garcia-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299.
11. Bavari S., Bosio C.M., Wiegand E., Ruthel G., Will A.B., Geisbert T.W., Hevey M., Schmaljohn C., Schmaljohn A., Aman M.J. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. The Journal of experimental medicine. 2002, 195:593-602.
12. Belyi V.A., Levine A.J., Skalka A.M. Unexpected inheritance. multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathogens 2010, 6:e1001030.
13. Bennett M. Bats and human emerging diseases. Epidemiology and Infection 2006, 134:905-907.
14. Bennett W.E., Cohn Z.A. The isolation and selected properties of blood monocytes. Journal of Experimental Medicine 1966, 123:145-160.
15. Bhattacharyya S., Warfield K.L., Ruthel G., Bavari S., Aman M.J., Hope T.J. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010, 401:18-28.
16. Bosio C.M., Aman M.J., Grogan C., Hogan R., Ruthel G., Negley D., Mohamadzadeh M., Bavari S., Schmaljohn A. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. Journal of Infectious Diseases 2003, 188:1630-1638.
17. Bosio C.M., Moore B.D., Warfield K.L., Ruthel G., Mohamadzadeh M., Aman M.J., Bavari S. Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology 2004, 326:280-287.
18. Bradfute S.B., Bavari S. Correlates of immunity to filovirus infection. Viruses 2011, 3:982-1000.
19. Bradfute S.B., Warfield K.L., Bavari S. Functional CD8+ T cell responses in lethal Ebola virus infection. Journal of Immunology 2008, 180:4058-4066.
20. Bray M. Pathogenesis of viral hemorrhagic fever. Current Opinion in Immunology 2005, 17:399-403.
21. Bray M., Davis K., Geisbert T., Schmaljohn C., Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. Journal of Infectious Diseases 1999, 179(Suppl 1):S248-258.
22. Bray M., Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. The international journal of biochemistry & cell biology. 2005, 37:1560-1566.
23. Cardenas W.B., Loo Y.M., Gale M., Hartman A.L., Kimberlin C.R., Martinez-Sobrido L., Saphire E.O., Basler C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. Journal of Virology 2006, 80:5168-5178.
24. Carette J.E., Raaben M., Wong A.C., Herbert A.S., Obernosterer G., Mulherkar N., Kuehne A.I., Kranzusch P.J., Griffin A.M., Ruthel G., Cin P.D., Dye J.M., Whelan S.P., Chandran K., Brummelkamp T.R. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011, 477:340-343.
25. Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., Goldsmith M.A. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001, 106:117-126.
26. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., Cunningham J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005, 308:1643-1645.
27. Chang T.H., Kubota T., Matsuoka M., Jones S., Bradfute S.B., Bray M., Ozato K. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathogens 2009, 5:e1000493.
28. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nature Immunology 2004, 5:1219-1226.
29. Connolly B.M., Steele K.E., Davis K.J., Geisbert T.W., Kell W.M., Jaax N.K., Jahrling P.B. Pathogenesis of experimental Ebola virus infection in guinea pigs. The Journal of infectious diseases. 1999, 179:S203-217.
30. Cote M., Misasi J., Ren T., Bruchez A., Lee K., Filone C.M., Hensley L., Li Q., Ory D., Chandran K., Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011.
31. Crowley M., Inaba K., Witmer-Pack M., Steinman R.M. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cellular Immunology 1989, 118:108-125.
32. Davis K.J., Anderson A.O., Geisbert T.W., Steele K.E., Geisbert J.B., Vogel P., Connolly B.M., Huggins J.W., Jahrling P.B., Jaax N.K. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Archives of pathology & laboratory medicine. 1997, 121:805-819.
33. Doherty P.C., Zinkernagel R.M. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Journal of Experimental Medicine 1975, 141:502-507.
34. Dominguez-Soto A., Aragoneses-Fenoll L., Martin-Gayo E., Martinez-Prats L., Colmenares M., Naranjo-Gomez M., Borras F.E., Munoz P., Zubiaur M., Toribio M.L., Delgado R., Corbi A.L. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood 2007, 109:5337-5345.
35. Dube D., Brecher M.B., Delos S.E., Rose S.C., Park E.W., Schornberg K.L., Kuhn J.H., White J.M. The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. Journal of Virology 2009, 83:2883-2891.
36. Dube D., Schornberg K.L., Shoemaker C.J., Delos S.E., Stantchev T.S., Clouse K.A., Broder C.C., White J.M. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc Natl Acad Sci U S A 2010, 107:16637-16642.
37. Dube D., Schornberg K.L., Stantchev T.S., Bonaparte M.I., Delos S.E., Bouton A.H., Broder C.C., White J.M. Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection. Journal of Virology 2008, 82:7238-7242.
38. Ebihara H., Groseth A., Neumann G., Kawaoka Y., Feldmann H. The role of reverse genetics systems in studying viral hemorrhagic fevers. Thrombosis and haemostasis. 2005, 94:240-253.
39. Ebihara H., Takada A., Kobasa D., Jones S., Neumann G., Theriault S., Bray M., Feldmann H., Kawaoka Y. Molecular determinants of Ebola virus virulence in mice. PLoS Pathogens 2006, 2:e73.
40. Empig C.J., Goldsmith M.A. Association of the Caveola Vesicular System with Cellular Entry by Filoviruses. Journal of Virology 2002, 76:5266-5270.
41. Falzarano D., Krokhin O., Van Domselaar G., Wolf K., Seebach J., Schnittler H.J., Feldmann H. Ebola sGP-the first viral glycoprotein shown to be C-mannosylated. Virology 2007, 368:83-90.
42. Feldmann H., Bugany H., Mahner F., Klenk H.D., Drenckhahn D., Schnittler H.J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. Journal of Virology 1996, 70:2208-2214.
43. Feldmann H., Jones S., Klenk H.D., Schnittler H.J. Ebola virus: from discovery to vaccine. Nature Reviews Immunology 2003, 3:677-685.
44. Feldmann H., Klenk H.D. Ebola and Marburg viruses: molecular and cellular biology 2004, Horizon Bioscience, Wymondham.
45. Ferenbach D., Hughes J. Macrophages and dendritic cells: what is the difference?. Kidney International 2008, 74:5-7.
46. Francica J.R., Matukonis M.K., Bates P. Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 2009, 383:237-247.
47. Francica J.R., Varela-Rohena A., Medvec A., Plesa G., Riley J.L., Bates P. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS Pathogens 2010, 6.
48. Fujii H., Watanabe S., Yamane D., Ueda N., Iha K., Taniguchi S., Kato K., Tohya Y., Kyuwa S., Yoshikawa Y., Akashi H. Functional analysis of Rousettus aegyptiacus " signal transducer and activator of transcription 1" (STAT1). Developmental and Comparative Immunology 2010, 34:598-602.
49. Garver W.S., Xie C., Repa J.J., Turley S.D., Dietschy J.M. Niemann-Pick C1 expression is not regulated by the amount of cholesterol flowing through cells in the mouse. Journal of Lipid Research 2005, 46:1745-1754.
50. Gautier E.L., Jakubzick C., Randolph G.J. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:1412-1418.
51. Gautier E.L., Jakubzick C., Randolph G.J. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2009, 29:1412-1418.
52. Gear J.S., Cassel G.A., Gear A.J., Trappler B., Clausen L., Meyers A.M., Kew M.C., Bothwell T.H., Sher R., Miller G.B., Schneider J., Koornhof H.J., Gomperts E.D., Isaacson M., Gear J.H. Outbreake of Marburg virus disease in Johannesburg. Br Med J 1975, 4:489-493.
53. Geisbert T.W., Hensley L.E. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert reviews in molecular medicine [electronic resource]. 2004, 6:1-24.
54. Geisbert T.W., Hensley L.E., Gibb T.R., Steele K.E., Jaax N.K., Jahrling P.B. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Laboratory Investigation; A Journal of Technical Methods and, Pathology 2000, 80:171-186.
55. Geisbert T.W., Hensley L.E., Jahrling P.B., Larsen T., Geisbert J.B., Paragas J., Young H.A., Fredeking T.M., Rote W.E., Vlasuk G.P. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003, 362:1953-1958.
56. Geisbert T.W., Hensley L.E., Larsen T., Young H.A., Reed D.S., Geisbert J.B., Scott D.P., Kagan E., Jahrling P.B., Davis K.J. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. The American journal of pathology. 2003, 163:2347-2370.
57. Geisbert T.W., Jahrling P.B., Hanes M.A., Zack P.M. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. Journal of comparative pathology. 1992, 106:137-152.
58. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Kagan E., Hensley L.E. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. The Journal of infectious diseases. 2003, 188:1618-1629.
59. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Larsen T., Kagan E., Hensley L.E. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. The American journal of pathology. 2003, 163:2371-2382.
60. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
61. Gibb T.R., Bray M., Geisbert T.W., Steele K.E., Kell W.M., Davis K.J., Jaax N.K. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. Journal of Comparative Pathology 2001, 125:233-242.
62. Gramberg T., Hofmann H., Moller P., Lalor P.F., Marzi A., Geier M., Krumbiegel M., Winkler T., Kirchhoff F., Adams D.H., Becker S., Munch J., Pohlmann S. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005, 340:224-236.
63. Gramberg T., Soilleux E., Fisch T., Lalor P.F., Hofmann H., Wheeldon S., Cotterill A., Wegele A., Winkler T., Adams D.H., Pohlmann S. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding. Virology 2008, 373:189-201.
64. Gupta M., Goldsmith C.S., Metcalfe M.G., Spiropoulou C.F., Rollin P.E. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus. Virology 2010, 402:203-208.
65. Gupta M., Mahanty S., Ahmed R., Rollin P.E. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 2001, 284:20-25.
66. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., Mirazimi A., Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008, 3:e2032.
67. Harcourt B.H., Sanchez A., Offermann M.K. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 1998, 252:179-188.
68. Harcourt B.H., Sanchez A., Offermann M.K. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. Journal of Virology 1999, 73:3491-3496.
69. Hartman A.L., Bird B.H., Towner J.S., Antoniadou Z.A., Zaki S.R., Nichol S.T. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. Journal of Virology 2008, 82:2699-2704.
70. Hartman A.L., Dover J.E., Towner J.S., Nichol S.T. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. Journal of Virology 2006, 80:6430-6440.
71. Hartman A.L., Ling L., Nichol S.T., Hibberd M.L. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. Journal of Virology 2008, 82:5348-5358.
72. He G., He B., Racey P.A., Cui J. Positive selection of the bat interferon alpha gene family. Biochemical Genetics 2010, 48:840-846.
73. Hensley L.E., Stevens E.L., Yan S.B., Geisbert J.B., Macias W.L., Larsen T., Daddario-DiCaprio K.M., Cassell G.H., Jahrling P.B., Geisbert T.W. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. Journal of Infectious Diseases 2007, 196(Suppl 2):S390-399.
74. Hensley L.E., Young H.A., Jahrling P.B., Geisbert T.W. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunology letters. 2002, 80:169-179.
75. Hervas-Stubbs S., Perez-Gracia J.L., Rouzaut A., Sanmamed M.F., Le Bon A., Melero I. Direct effects of type I interferons on cells of the immune system. Clin Cancer Res 2011, 17:2619-2627.
76. Hood C.L., Abraham J., Boyington J.C., Leung K., Kwong P.D., Nabel G.J. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. Journal of Virology 2010, 84:2972-2982.
77. Hume D.A. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunology 2008, 1:432-441.
78. Ito H., Watanabe S., Sanchez A., Whitt M.A., Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. Journal of virology. 1999, 73:8907-8912.
79. Janeway C.A., Medzhitov R. Innate immune recognition. Annual Review of Immunology 2002, 20:197-216.
80. Jasenosky L.D., Neumann G., Lukashevich I., Kawaoka Y. Ebola virus VP40-induced particle formation and association with the lipid bilayer. Journal of virology. 2001, 75:5205-5214.
81. Jin H., Yan Z., Prabhakar B.S., Feng Z., Ma Y., Verpooten D., Ganesh B., He B. The VP35 Protein of Ebola Virus Impairs Dendritic Cell Maturation Induced by Virus and Lipopolysaccharide. Journal of General Virology 2009.
82. Johnson W.D., Mei B., Cohn Z.A. The separation, long-term cultivation, and maturation of the human monocyte. Journal of Experimental Medicine 1977, 146:1613-1626.
83. Kaletsky R.L., Simmons G., Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. Journal of Virology 2007, 81:13378-13384.
84. Kash J.C., Muhlberger E., Carter V., Grosch M., Perwitasari O., Proll S.C., Thomas M.J., Weber F., Klenk H.D., Katze M.G. Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. Journal of Virology 2006, 80:3009-3020.
85. Kepler T.B., Sample C., Hudak K., Roach J., Haines A., Walsh A., Ramsburg E.A. Chiropteran types I and II interferon genes inferred from genome sequencing traces by a statistical gene-family assembler. BMC Genomics 2010, 11:444.
86. Kimberlin C.R., Bornholdt Z.A., Li S., Woods V.L., MacRae I.J., Saphire E.O. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 2010, 107:314-319.
87. Kobayashi N., Karisola P., Pena-Cruz V., Dorfman D.M., Jinushi M., Umetsu S.E., Butte M.J., Nagumo H., Chernova I., Zhu B., Sharpe A.H., Ito S., Dranoff G., Kaplan G.G., Casasnovas J.M., Umetsu D.T., Dekruyff R.H., Freeman G.J. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007, 27:927-940.
88. Kondratowicz A.S., Lennemann N.J., Sinn P.L., Davey R.A., Hunt C.L., Moller-Tank S., Meyerholz D.K., Rennert P., Mullins R.F., Brindley M., Sandersfeld L.M., Quinn K., Weller M., McCray P.B., Chiorini J., Maury W. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A 2011, 108:8426-8431.
89. Kortepeter M.G., Bausch D.G., Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. Journal of Infectious Diseases 2011, 204(Suppl 3):S810-816.
90. Kuchroo V.K., Dardalhon V., Xiao S., Anderson A.C. New roles for TIM family members in immune regulation. Nature Reviews Immunology 2008, 8:577-580.
91. Kuhn J.H., Becker S., Ebihara H., Geisbert T.W., Johnson K.M., Kawaoka Y., Lipkin W.I., Negredo A.I., Netesov S.V., Nichol S.T., Palacios G., Peters C.J., Tenorio A., Volchkov V.E., Jahrling P.B. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology 2010, 155:2083-2103.
92. Kuhn J.H., Radoshitzky S.R., Guth A.C., Warfield K.L., Li W., Vincent M.J., Towner J.S., Nichol S.T., Bavari S., Choe H., Aman M.J., Farzan M. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. Journal of Biological Chemistry 2006, 281:15951-15958.
93. Lee J.E., Saphire E.O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol 2009, 4:621-635.
94. Leung D.W., Ginder N.D., Fulton D.B., Nix J., Basler C.F., Honzatko R.B., Amarasinghe G.K. Structure of the Ebola VP35 interferon inhibitory domain. Proc Natl Acad Sci U S A 2009, 106:411-416.
95. Leung D.W., Prins K.C., Borek D.M., Farahbakhsh M., Tufariello J.M., Ramanan P., Nix J.C., Helgeson L.A., Otwinowski Z., Honzatko R.B., Basler C.F., Amarasinghe G.K. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nature Structural & Molecular Biology 2010, 17:165-172.
96. Leung L., Martinez O., Reynard O., Volchkov V., Basler C. Ebola Virus Failure to Stimulate Plasmacytoid Dendritic Cell Interferon Responses Correlates With Impaired Cellular Entry. Journal of Infectious Diseases 2011, 204(Suppl 3):S973-S977.
97. Leung L.W., Park M.S., Martinez O., Valmas C., Lopez C.B., Basler C.F. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunology and Cell Biology 2011, 89:792-802.
98. Levi M., Ten Cate H. Disseminated intravascular coagulation. New England Journal of Medicine 1999, 341:586-592.
99. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. Journal of Virology 2003, 77:1337-1346.
100. Lopez C.B., Yount J.S., Moran T.M. Toll-like receptor-independent triggering of dendritic cell maturation by viruses. Journal of Virology 2006, 80:3128-3134.
101. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
102. Mahanty S., Hutchinson K., Agarwal S., McRae M., Rollin P.E., Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. Journal of Immunology 2003, 170:2797-2801.
103. Martinez O., Johnson J., Manicassamy B., Rong L., Olinger G.G., Hensley L.E., Basler C.F. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology 2010, 12:148-157.
104. Martinez O., Valmas C., Basler C.F. Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology 2007, 364:342-354.
105. Marzi A., Moller P., Hanna S.L., Harrer T., Eisemann J., Steinkasserer A., Becker S., Baribaud F., Pohlmann S. Analysis of the Interaction of Ebola Virus Glycoprotein with DC-SIGN (Dendritic Cellâ€" Specific Intercellular Adhesion Molecule 3â€" Grabbing Nonintegrin) and Its Homologue DC-SIGNR. The Journal of Infectious Diseases 2007, 196:S237-S246.
106. Mateo M., Carbonnelle C., Reynard O., Kolesnikova L., Nemirov K., Page A., Volchkova V.A., Volchkov V.E. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. Journal of Infectious Diseases 2011, 204(Suppl 3):S1011-1020.
107. Mateo M., Reid S.P., Leung L.W., Basler C.F., Volchkov V.E. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. Journal of Virology 2010, 84:1169-1175.
108. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
109. Morris D.L., Singer K., Lumeng C.N. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr Opin Clin Nutr Metab Care 2011, 14:341-346.
110. Mortellaro A., Wong S.C., Fric J., Ricciardi-Castagnoli P. The need to identify myeloid dendritic cell progenitors in human blood. Trends in immunology 2010, 31:18-23.
111. Mulherkar N., Raaben M., de la Torre J.C., Whelan S.P., Chandran K. The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology 2011, 419:72-83.
112. Nanbo A., Imai M., Watanabe S., Noda T., Takahashi K., Neumann G., Halfmann P., Kawaoka Y. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathogens 2010, 6.
113. Negredo A., Palacios G., Vazquez-Moron S., Gonzalez F., Dopazo H., Molero F., Juste J., Quetglas J., Savji N., de la Cruz Martinez M., Herrera J.E., Pizarro M., Hutchison S.K., Echevarria J.E., Lipkin W.I., Tenorio A. Discovery of an ebolavirus-like filovirus in europe. PLoS Pathogens 2011, 7:e1002304.
114. Neumann G., Feldmann H., Watanabe S., Lukashevich I., Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. Journal of virology. 2002, 76:406-410.
115. Neumann G., Geisbert T.W., Ebihara H., Geisbert J.B., Daddario-DiCaprio K.M., Feldmann H., Kawaoka Y. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. Journal of Virology 2007, 81:2995-2998.
116. Noda T., Sagara H., Suzuki E., Takada A., Kida H., Kawaoka Y. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. Journal of virology. 2002, 76:4855-4865.
117. Okumura A., Pitha P.M., Yoshimura A., Harty R.N. Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. Journal of Virology 2010, 84:27-33.
118. Omatsu T., Bak E.J., Ishii Y., Kyuwa S., Tohya Y., Akashi H., Yoshikawa Y. Induction and sequencing of Rousette bat interferon alpha and beta genes. Veterinary Immunology and Immunopathology 2008, 124:169-176.
119. Piccioli D., Tavarini S., Borgogni E., Steri V., Nuti S., Sammicheli C., Bardelli M., Montagna D., Locatelli F., Wack A. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007, 109:5371-5379.
120. Prins K.C., Cardenas W.B., Basler C.F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. Journal of Virology 2009, 83:3069-3077.
121. Prins K.C., Delpeut S., Leung D.W., Reynard O., Volchkova V.A., Reid S.P., Ramanan P., Cardenas W.B., Amarasinghe G.K., Volchkov V.E., Basler C.F. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. Journal of Virology 2010, 84:3004-3015.
122. Randolph G.J., Jakubzick C., Qu C. Antigen presentation by monocytes and monocyte-derived cells. Current Opinion in Immunology 2008, 20:52-60.
123. Ray R.B., Basu A., Steele R., Beyene A., McHowat J., Meyer K., Ghosh A.K., Ray R. Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology 2004, 321:181-188.
124. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. Journal of Virology 2006, 80:5156-5167.
125. Reid S.P., Valmas C., Martinez O., Sanchez F.M., Basler C.F. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. Journal of Virology 2007, 81:13469-13477.
126. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annual Review of Immunology 2011, 29:163-183.
127. Reynard O., Borowiak M., Volchkova V.A., Delpeut S., Mateo M., Volchkov V.E. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. Journal of Virology 2009, 83:9596-9601.
128. Robinson M.J., Sancho D., Slack E.C., LeibundGut-Landmann S., Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nature immunology 2006, 7:1258-1265.
129. Rodriguez-Manzanet R., DeKruyff R., Kuchroo V.K., Umetsu D.T. The costimulatory role of TIM molecules. Immunological Reviews 2009, 229:259-270.
130. Ruf W. Emerging roles of tissue factor in viral hemorrhagic fever. Trends in immunology. 2004, 25:461-464.
131. Ryabchikova E.I., Kolesnikova L.V., Luchko S.V. An analysis of features of pathogenesis in two animal models of Ebola virus infection. The Journal of Infectious Diseases 1999, 179:S199-S202.
132. Saeed M.F., Kolokoltsov A.A., Albrecht T., Davey R.A. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathogens 2010, 6.
133. Sanchez A., Lukwiya M., Bausch D., Mahanty S., Sanchez A.J., Wagoner K.D., Rollin P.E. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. Journal of Virology 2004, 78:10370-10377.
134. Sanchez A.G., Thomas W., Feldmann, Heinz Marburg and Ebola Viruses 2007, Lippincott Williams and Wilkins, Filoviridae.
135. Schnittler H.J., Feldmann H. Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?. Clinical Infectious Diseases 1998, 27:404-406.
136. Schnittler H.J., Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thrombosis and Haemostasis 2003, 89:967-972.
137. Schornberg K., Matsuyama S., Kabsch K., Delos S., Bouton A., White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. Journal of Virology 2006, 80:4174-4178.
138. Shabman R.S., Gulcicek E.E., Stone K.L., Basler C.F. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import. J Infect Dis 2011, 204(Supply 3):S904-S910.
139. Shabo I., Svanvik J. Expression of macrophage antigens by tumor cells. Advances in experimental medicine and biology 2011, 714:141-150.
140. Shimojima M., Takada A., Ebihara H., Neumann G., Fujioka K., Irimura T., Jones S., Feldmann H., Kawaoka Y. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. Journal of Virology 2006, 80:10109-10116.
141. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., Pohlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123.
142. Simmons G., Wool-Lewis R.J., Baribaud F., Netter R.C., Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. Journal of Virology 2002, 76:2518-2528.
143. Steinman R.M. Decisions About Dendritic Cells: Past, Present, and Future. Annual Review of Immunology 2011.
144. Steinman R.M., Idoyaga J. Features of the dendritic cell lineage. Immunological Reviews 2010, 234:5-17.
145. Steinman R.M., Idoyaga J. Features of the dendritic cell lineage. Immunological Reviews 2010, 234:5-17.
146. Stroher U., West E., Bugany H., Klenk H.D., Schnittler H.J., Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. Journal of Virology 2001, 75:11025-11033.
147. Sullivan N.J., Peterson M., Yang Z.Y., Kong W.P., Duckers H., Nabel E., Nabel G.J. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. Journal of Virology 2005, 79:547-553.
148. Swanepoel R., Smit S.B., Rollin P.E., Formenty P., Leman P.A., Kemp A., Burt F.J., Grobbelaar A.A., Croft J., Bausch D.G., Zeller H., Leirs H., Braack L.E., Libande M.L., Zaki S., Nichol S.T., Ksiazek T.G., Paweska J.T. Studies of reservoir hosts for Marburg virus. Emerging Infectious Diseases 2007, 13:1847-1851.
149. Swenson D.L., Warfield K.L., Kuehl K., Larsen T., Hevey M.C., Schmaljohn A., Bavari S., Aman M.J. Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunology and Medical Microbiology 2004, 40:27-31.
150. Takada A., Fujioka K., Tsuiji M., Morikawa A., Higashi N., Ebihara H., Kobasa D., Feldmann H., Irimura T., Kawaoka Y. Human Macrophage C-Type Lectin Specific for Galactose and N-Acetylgalactosamine Promotes Filovirus Entry. Journal of Virology 2004, 78:2943-2947.
151. Takada A., Watanabe S., Ito H., Okazaki K., Kida H., Kawaoka Y. Downregulation of [beta]1 Integrins by Ebola Virus Glycoprotein: Implication for Virus Entry. Virology 2000, 278:20-26.
152. Towner J.S., Amman B.R., Sealy T.K., Carroll S.A., Comer J.A., Kemp A., Swanepoel R., Paddock C.D., Balinandi S., Khristova M.L., Formenty P.B., Albarino C.G., Miller D.M., Reed Z.D., Kayiwa J.T., Mills J.N., Cannon D.L., Greer P.W., Byaruhanga E., Farnon E.C., Atimnedi P., Okware S., Katongole-Mbidde E., Downing R., Tappero J.W., Zaki S.R., Ksiazek T.G., Nichol S.T., Rollin P.E. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathogens 2009, 5:e1000536.
153. Towner J.S., Pourrut X., Albarino C.G., Nkogue C.N., Bird B.H., Grard G., Ksiazek T.G., Gonzalez J.P., Nichol S.T., Leroy E.M. Marburg virus infection detected in a common African bat. PLoS ONE 2007, 2:e764.
154. Valmas C., Basler C.F. Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. Journal of Virology 2011, 85:4309-4317.
155. Valmas C., Grosch M.N., Schumann M., Olejnik J., Martinez O., Best S.M., Krahling V., Basler C.F., Muhlberger E. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathogens 2010, 6:e1000721.
156. Vestweber D. Regulation of endothelial cell contacts during leukocyte extravasation. Current Opinion in Cell Biology 2002, 14:587-593.
157. Volchkov V.E., Feldmann H., Volchkova V.A., Klenk H.D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 1998, 95:5762-5767.
158. Wahl-Jensen V., Kurz S., Feldmann F., Buehler L.K., Kindrachuk J., DeFilippis V., da Silva Correia J., Fruh K., Kuhn J.H., Burton D.R., Feldmann H. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl Trop Dis 2011, 5:e1359.
159. Wahl-Jensen V., Kurz S.K., Hazelton P.R., Schnittler H.J., Stroher U., Burton D.R., Feldmann H. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. Journal of Virology 2005, 79:2413-2419.
160. Wahl-Jensen V.M., Afanasieva T.A., Seebach J., Stroher U., Feldmann H., Schnittler H.J. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. Journal of Virology 2005, 79:10442-10450.
161. Warfield K.L., Aman M.J. Advances in virus-like particle vaccines for filoviruses. Journal of Infectious Diseases 2011, 204(Suppl 3):S1053-1059.
162. Warfield K.L., Bosio C.M., Welcher B.C., Deal E.M., Mohamadzadeh M., Schmaljohn A., Aman M.J., Bavari S. Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A 2003, 100:15889-15894.
163. Warfield K.L., Posten N.A., Swenson D.L., Olinger G.G., Esposito D., Gillette W.K., Hopkins R.F., Costantino J., Panchal R.G., Hartley J.L., Aman M.J., Bavari S. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. Journal of Infectious Diseases 2007, 196(Suppl 2):S421-429.
164. Watanabe S., Takada A., Watanabe T., Ito H., Kida H., Kawaoka Y. Functional Importance of the Coiled-Coil of the Ebola Virus Glycoprotein. Journal of Virology 2000, 74:10194-10201.
165. Watanabe S., Watanabe T., Noda T., Takada A., Feldmann H., Jasenosky L.D., Kawaoka Y. Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics. Journal of Virology 2004, 78:999-1005.
166. Wauquier N., Becquart P., Padilla C., Baize S., Leroy E.M. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010, 4.
167. Weissenhorn W., Carfi A., Lee K.H., Skehel J.J., Wiley D.C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Molecular Cell 1998, 2:605-616.
168. Wong A.C., Sandesara R.G., Mulherkar N., Whelan S.P., Chandran K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. Journal of Virology 2010, 84:163-175.
169. Wool-Lewis R.J., Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. Journal of Virology 1999, 73:1419-1426.
170. Wyers M., Formenty P., Cherel Y., Guigand L., Fernandez B., Boesch C., Le Guenno B. Histopathological and Immunohistochemical Studies of Lesions Associated with Ebola Virus in a Naturally Infected Chimpanzee. The Journal of Infectious Diseases 1999, 179:S54-S59.
171. Xiao S., Zhu B., Jin H., Zhu C., Umetsu D.T., DeKruyff R.H., Kuchroo V.K. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. European Journal of Immunology 2011, 41:1539-1549.
172. Yang Z., Delgado R., Xu L., Todd R.F., Nabel E.G., Sanchez A., Nabel G.J. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 1998, 279:1034-1037.
173. Yang Z.Y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E.G., Nabel G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nature Medicine 2000, 6:886-889.
174. Ye L., Lin J., Sun Y., Bennouna S., Lo M., Wu Q., Bu Z., Pulendran B., Compans R.W., Yang C. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology 2006.
175. Yonezawa A., Cavrois M., Greene W.C. Studies of Ebola Virus Glycoprotein-Mediated Entry and Fusion by Using Pseudotyped Human Immunodeficiency Virus Type 1 Virions: Involvement of Cytoskeletal Proteins and Enhancement by Tumor Necrosis Factor Alpha. Journal of Virology 2005, 79:918-926.
176. Zaki S.R., Shieh W.J., Greer P.W., Goldsmith C.S., Ferebee T., Katshitshi J., Tshioko F.K., Bwaka M.A., Swanepoel R., Calain P., Khan A.S., Lloyd E., Rollin P.E., Ksiazek T.G., Peters C.J. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. Journal of Infectious Diseases 1999, 179(Suppl 1):S36-47.
177. Zampieri C.A., Fortin J.F., Nolan G.P., Nabel G.J. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. Journal of Virology 2007, 81:1230-1240.
178. Zuckerman S.H., Ackerman S.K., Douglas S.D. Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 1979, 38:401-411.